Neue Pinnwand erstellen
Editorial-Bilder

GERMANY-HEALTH-VIRUS-BIONTECH-VACCINES

Employees in cleanroom suits test the procedures for the manufacturing of the messenger RNA (mRNA) for the Covid-19 vaccine at the new manufacturing site of German company BioNTech on March 27, 2021 in Marburg, central Germany. - German firm BioNTech said on March 30, 2021 it was on track to manufacture 2.5 billion doses of its Covid-19 vaccine this year with US partner Pfizer, 25 percent more than previously expected. (Photo by Thomas Lohnes / AFP) (Photo by THOMAS LOHNES/AFP via Getty Images)
GERMANY-HEALTH-VIRUS-BIONTECH-VACCINES
Bild einbetten